Press releases

Boston Scientific will participate in the healthcare investor conference on June 7, 2016. A live webcast and replay will be available.

Full-body MRI access expands spinal cord stimulation offering and brings customized therapy to more patients suffering from chronic pain

Key data to be presented include real-world outcomes with the with the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device in Europe

Late-breaker data presented at HRS scientific sessions is most extensive post-market study for S-ICD

New catheters and software enhancement expand capabilities of high-definition Rhythmia™ Mapping System

Boston Scientific will participate in the healthcare investor conference on May 12, 2016. A live webcast and replay will be available.

Boston Scientific (NYSE: BSX) today announced key data, including one late-breaking clinical trial, that will be featured at the 37th Annual Scientific Sessions of the Heart Rhythm Society (HRS)...

"This strong start enables us to raise our outlook for the year,” said Boston Scientific CEO Mike Mahoney

FDA approval includes ACCOLADE™ MRI and ESSENTIO™ MRI pacemakers and INGEVITY™ MRI pacing leads

Boston Scientific will participate in the healthcare investor conference on May 5, 2016. A live webcast and replay will be available.

European approval granted for third-generation system and all previously implanted, second-generation systems

No reports of patient injury or death; no risk to patients who previously underwent a thrombectomy with the Fetch 2 catheter

The company rejects the allegations in the petition to the Food and Drug Administration filed by a Texas-based law firm

Boston Scientific will webcast its conference call with financial results and business highlights for Q1 ended March 31, 2016. Learn how to tune in.

Boston Scientific will participate in the healthcare conference on April 12, 2016. A live webcast and replay will be available.

Scheduled abstracts will highlight 'real-world' and clinical trial experiences with technologies developed to treat patients with a range of cardiovascular diseases

Boston Scientific Corporation (NYSE: BSX) today announced the launch of the AXIOS™ Stent and Electrocautery Enhanced Delivery System to help physicians manage two serious complications from...

Two organizations to share intellectual property and stimulate the rapid development of medical devices to address unmet clinical needs

FDA approval granted on the heels of CE Mark for the IntellaTip MiFi™ open-irrigated catheter

Boston Scientific will participate in the healthcare conference on March 15, 2016. Learn how to watch the webcast or replay.

Chairman Pete Nicholas to retire; President and CEO Mike Mahoney to become chairman

Boston Scientific will participate in the healthcare conference on March 8, 2016. Learn how to watch the webcast or replay.

ACUITY™ X4 Quadripolar Left Ventricular Leads to be used in trial pursuing MRI labeling for cardiac defibrillation and resynchronization systems

First polymer-based, drug-eluting stent designed to treat peripheral lesions above the knee approved in Europe

CMS will cover percutaneous LAAC therapy for Medicare beneficiaries consistent with the FDA label when specific conditions are met